Valeo Pharma Competitors and Similar CompaniesClear all

Valeo Pharma's competitors and similar companies include Mankind Pharma, EMS Pharma, Alembic Pharmaceuticals and Genentech.

	Valeo Pharma Valeo Pharma is a pharmaceutical company that provides healthcare professionals and patients with specialty products and healthcare solutions.	Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.	EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.	Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
Founding Date	Founding Date 2003	Founding Date 1995	Founding Date 1964	Founding Date 2010	Founding Date 1976
Type	Type Public	Type Private	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Kirkland, CA HQ	Locations New Delhi, IN HQ	Locations BR HQ	Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more
Employees	Employees 105	Employees 16,2532% increase	Employees 12,7441% increase	Employees 14,858	Employees 18,077
Financial
Revenue (est.)	Revenue (est.) $53.9m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹73.4b (FY, 2026)	Revenue (est.) N/A
Cost of goods	Cost of goods $37.6m (FY, 2023)	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹19.8b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit $16.4m (FY, 2023)	Gross profit N/A	Gross profit N/A	Gross profit ₹54.1b (FY, 2026)	Gross profit N/A
Net income	Net income ($27.8m) (FY, 2023)	Net income N/A	Net income N/A	Net income ₹6.7b (FY, 2026)	Net income N/A